期刊文献+

CXC趋化因子受体3的单克隆抗体抑制体外培养的MCF-7细胞和HepG2细胞的增殖及迁移

CXCR3 monoclonal antibody inhibits the proliferation and migration of MCF-7 cells and HepG2 cells in vitro
下载PDF
导出
摘要 目的研究CXC趋化因子受体3(CXCR3)单克隆抗体(mAb)对MCF-7人乳腺癌细胞和HepG2人肝癌细胞体外增殖及迁移的影响。方法诱生腹水法制备CXCR3 m Ab;流式细胞术筛选高表达CXCR3的MCF-7细胞和HepG2细胞;MTT法检测CXCR3 mAb对MCF-7细胞和HepG2细胞增殖及干扰素诱导的T细胞α趋化因子(I-TAC)对MCF-7细胞和HepG2细胞促增殖的影响;TranswellTM法研究CXCR3 mAb对MCF-7细胞和HepG2细胞迁移及I-TAC对MCF-7细胞和HepG2细胞促迁移的影响。结果 MCF-7细胞和HepG2细胞CXCR3的阳性表达率分别为83.5%和96.2%;50μg/m L CXCR3 m Ab能够显著的抑制MCF-7细胞和HepG2细胞的增殖并抑制I-TAC对MCF-7细胞和HepG2细胞的促增殖作用;50μg/m L CXCR3 m Ab可抑制MCF-7细胞和HepG2细胞的迁移,并抑制I-TAC对MCF-7细胞和HepG2细胞促迁移作用。结论 CXCR3 mAb能够显著地抑制高表达CXCR3的肿瘤细胞的增殖及迁移。 Objective To study the effects of chemokine (C-X-C motif) receptor 3 (CXCR3) monoclonal antibody (mAb) on the proliferation and migration of MCF-7 and HepG2 cells in vitro. Methods Ascites of CXCR3 mAb was prepared at first. MCF-7 and HepG2 cells with high expressions of CXCR3 were screened by flow cytometry. MTT assay was used to detect the effects of CXCR3 mAb on the proliferation of MCF-7 and HepG2 cells in vitro in the absence/presence of interferoninducible T-cell alpha chemoattractant (I-TAC). Transwell^TM assay was performed to investigate the effects of CXCR3 mAb on the migration of MCF-7 and HepG2 cells in vitro in the absence/presence of I-TAC. Results The expression rate of CXCR3 on MCF-7 and HepG2 cells were 83.5% and 96.2%, respectively. 50 μg/mL CXCR3 mAb significantly inhibited the proliferation and migration of MCF-7 and HepG2 cells, and also inhibited the promoting effect of I-TAC on the proliferation and migration of MCF-7 and HepG2 cells in vitro. Conclusion CXCR3 mAb can significantly inhibit the proliferation and migration of the tumor ceils highly expressing CXCR3 in vitro.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2015年第11期1544-1548,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81373236)
关键词 CXC趋化因子受体3(CXCR3) 单克隆抗体 肿瘤 增殖 迁移 CXCR3 monoclonal antibody tumor proliferation migration
  • 相关文献

参考文献3

二级参考文献33

  • 1Liping L, Melissa KC, De RH, et al. Chemokine receptor CXCR3: an unexpected enigma [ M ]. Curr Top Dev Biol, 2005, 68 : 149 - 181.
  • 2Marcel L, Pius L, Nicole B, et al. Lymphocyte-specific chemokine receptor CXCR3 : regulation, chemokine, binding and gene localization[J]. Eur J Immunol, 1998, 28(14) : 3696 -3705.
  • 3Laura L, Michela F, Francesco A, et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor4[ J]. J Exp Med, 2003, 197( 11 ) : 1537 - 1549.
  • 4Steinmetz OM, Turner JE, Paust HJ, et al. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis[J]. J Immunol, 2009, 183(7): 4693-4704.
  • 5Kohlmeier JE, Cookenham T, Miller SC, et al. CXCR3 directs antigen-specific effector CD4^+ T cell migration to the lung during parainfluenza virus infection[ J]. J lmmunol, 2009, 183 (7) : 4378 -4384.
  • 6Thapa M, Carr DJ. CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8^+ T cell effector function but not migration [ J ]. J Virol, 2009, 83 (18 ) : 9486 - 9501.
  • 7Tonya CW, Salah R, Xinrong M, et al. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer[ J]. Cancer Res, 2006, 66: (15): 7701 -7707.
  • 8Vandercappellen J, Van Damme J, Struyf S. The role of CXC chemokines and their receptors in cancer[J]. Cancer Lett, 2008, 267(2) : 226 - 244.
  • 9Nicola G, Sabrina B, Paola R, et al. CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival [ J]. Haematologica, 2006, 91(11) : 1489-1497.
  • 10Kenji K, Masahiro S, Hiromi S, et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes [ J ]. Cancer Res, 2004, 64 (11) : 4010 -4017.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部